Here, we walk you through everything you need to know about CRISPR-Cas9, including what it is, how it works, and what we can expect from it in the future. CRISPR-Cas9 is a new technology for ...

Deanna earned their PhD in cellular biology from McGill University in 2020 and has a professional background in medical writing. They are an associate science editor at The Scientist. View Full ...

We’re talking about an unproven gene-editing technique called CRISPR-Cas9. It sounds like science fiction – until you learn that investors like Google and Bill Gates have contributed millions ...

Sickle cell disease, which can result in attacks of debilitating pain, is more common in people with an African or Caribbean family background ... The CRISPR-Cas9 gene editing technique allows ...

A new paper points to a previously unknown hurdle for scientists racing to develop therapies using the revolutionary genome-editing tool CRISPR-Cas9: the human immune system. In a study posted ...

She has a background in neuroscience ... points in the genome. Cas9, the first Cas protein repurposed for cutting DNA, introduces double-strand breaks that recruit DNA repair machinery. Despite its ...

Today, CRISPR/Cas9 is successfully adapted for genome editing of various organisms, offering a revolutionary technique for researchers around the world. It offers a number of advantages over other ...

For a decade, leading academic institutes and their associated companies fought a bruising, headline-grabbing fight over who held patent rights to CRISPR-Cas9, the revolutionary genome editing tool.

When the CRISPR Cas9 protein is added to a cell along with a piece of guide RNA, the Cas9 protein hooks up with the guide RNA and then moves along the strands of DNA until it finds and binds to a ...

CRISPR-Cas9 gene editing technology is widely used to to help study genes of interest and modify disease-associated genes. However, the system is associated with adverse effects, including ...

The Food and Drug Administration on Friday approved two gene therapies to treat sickle cell disease, one of the which is the first CRISPR/Cas9-based treatment to win regulatory approval in the US.